Neuregulin-4

N/A

Report date: 2023/03/13 17:21:56
NME

Base Information

Drug NameNeuregulin-4
Drug Alias NameNRG4
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuregulins stimulants
TargetsNeuregulins
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesEnterocolitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvexegen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvexegen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseInflammatory Bowel DiseasesEnterocolitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A